Par Drugs and Chemicals Limited (NSE:PAR)

India · Delayed Price · Currency is INR

101.33

-1.15 (-1.12%)

Aug 21, 2026, 3:29 PM IST

Par Drugs and Chemicals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,089	1,037	1,010	956.4	957.49	750.74
Revenue Growth	4.29%	2.66%	5.58%	-0.11%	27.54%	23.58%
Gross Profit	631.2	602.94	617.86	609.88	547.65	457.57
Operating Income	161.87	134.28	158.64	193.81	149.74	129.74
Net Income	144.93	131.09	133.58	145.01	113.34	92.13
Earnings Per Share	11.78	10.65	10.86	11.78	9.21	7.49
EPS Growth	2.44%	-1.90%	-7.84%	27.90%	23.00%	-20.64%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	752.29	718.17	751.19	562.73
Unallocated	4.27	5.34	6.54	8.74
Export	253.17	232.89	199.76	179.27
Total	1,010	956.4	957.49	750.74

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	418.43	418.43	275.77	366.54	222.43	162.06
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	418.43	418.43	275.77	366.54	222.43	162.06
Net Cash Growth	51.73%	51.73%	-24.76%	64.79%	37.25%	26.19%
Net Cash Per Share	34.01	33.99	22.41	29.79	18.08	13.17

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	164.32	161.6	202.49	133.77	76.15
Capital Expenditures	-	-19.62	-12.27	-60.8	-76.34	-32.02
Free Cash Flow	-	144.71	149.34	141.69	57.43	44.13
Free Cash Flow Growth	-	-3.10%	5.40%	146.69%	30.15%	-37.28%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	57.97%	58.17%	61.19%	63.77%	57.20%	60.95%
Operating Margin	14.87%	12.96%	15.71%	20.27%	15.64%	17.28%
Pretax Margin	17.59%	16.69%	17.75%	20.41%	15.75%	16.92%
Profit Margin	13.31%	12.65%	13.23%	15.16%	11.84%	12.27%
FCF Margin	-	13.96%	14.79%	14.81%	6.00%	5.88%

Dividends

Fiscal Year	FY 2022
Period Ending	Mar '22 Mar 31, 2022
Dividend Per Share	1.250
Dividend Per Share Growth	-
Dividend Yield	0.78%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 23, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	8.60	7.38	7.82	18.28	15.20	21.34
P/FCF Ratio	8.62	6.68	7.00	18.71	29.99	44.54
PS Ratio	1.15	0.93	1.03	2.77	1.80	2.62